![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Biosense Webster, Inc. |
---|---|
Information provided by: | Biosense Webster, Inc. |
ClinicalTrials.gov Identifier: | NCT00767390 |
The Purpose of this clinical investigation is to observe the changes in relative conductivity between the six ACL patches over time. In addition, the clinical investigation will evaluate the impact of prolonged placement of the ACL patches on subjects' skin on the chest and back. During the study the adhesiveness properties of the patches will be evaluated.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Device: ACL Patch |
Phase I Phase II |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | CARTO 3 ACL Patches Effectiveness Over Prolonged Clinical Case |
Estimated Enrollment: | 44 |
Study Start Date: | October 2008 |
Groups/Cohorts | Assigned Interventions |
---|---|
ACL Patch |
Device: ACL Patch
Observe and characterize the changes in relative conductivity between the six ACL patches over period of six hours. Investigation only involves passive data collection on pressure impact and adhesiveness properties of ACL patches.
|
Ages Eligible for Study: | 20 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Healthy Volunteers
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Biosense Webster, Inc. ( Pesach Susel, Project Director ) |
Study ID Numbers: | Rep2952 |
Study First Received: | October 3, 2008 |
Last Updated: | November 20, 2008 |
ClinicalTrials.gov Identifier: | NCT00767390 History of Changes |
Health Authority: | Israel: Ministry of Health |
ACL Patch Placement |
Healthy |